Virtual Total Agilent Experience 2021 - Day 2

Virtual Total Agilent Experience 2021 - Day 2

The symposium will feature innovative analytical technologies, expert talks on emerging trends in food, pharma and biopharma industries, and 1-to-1 interactions with our technical team.
RECORD
|
Already taken place Th, 8.7.2021
Th, 8.7.2021
Agilent Technologies
tag
share
more
Virtual Total Agilent Experience 2021 - Day 2
Robustness and Ruggedness studies in Method development – Insights and Regulations

Robustness and Ruggedness studies in Method development – Insights and Regulations

Being a reliable partner for your lab, we endeavor to continue providing you ROBUST analytical power to deliver HIGH EFFICIENCY to enhance your PRODUCTIVITY & PROFITABILITY.
RECORD
|
Already taken place We, 7.7.2021
We, 7.7.2021
Agilent Technologies
tag
share
more
Robustness and Ruggedness studies in Method development – Insights and Regulations
Drugs of Abuse Automated Screening vs Manual Testing: What are the Benefits?

Drugs of Abuse Automated Screening vs Manual Testing: What are the Benefits?

In this webinar, learn all about the trends of the Drugs of Abuse as a global problem and the essential factors to consider when starting Drugs of Abuse Testing.
RECORD
|
Already taken place We, 7.7.2021
We, 7.7.2021
Thermo Fisher Scientific
tag
share
more
Drugs of Abuse Automated Screening vs Manual Testing: What are the Benefits?
Virtual Total Agilent Experience 2021 - Day 1

Virtual Total Agilent Experience 2021 - Day 1

The symposium will feature innovative analytical technologies, expert talks on emerging trends in food, pharma and biopharma industries, and 1-to-1 interactions with our technical team.
RECORD
|
Already taken place We, 7.7.2021
We, 7.7.2021
Agilent Technologies
tag
share
more
Virtual Total Agilent Experience 2021 - Day 1
High Resolution Size Exclusion Chromatography (SEC) Analysis of Intact Protein Biotherapeutics

High Resolution Size Exclusion Chromatography (SEC) Analysis of Intact Protein Biotherapeutics

This presentation will highlight comprehensive workflows for the analytical characterization of proteins using SEC, ProA-SEC 2D-LC and SEC-MS.
RECORD
|
Already taken place Mo, 5.7.2021
Mo, 5.7.2021
Agilent Technologies
tag
share
more
High Resolution Size Exclusion Chromatography (SEC) Analysis of Intact Protein Biotherapeutics
The power of (U)HPLC selectivity for diverse pharmaceutical methods

The power of (U)HPLC selectivity for diverse pharmaceutical methods

With so much attention paid over the years to column efficiency, it is important not forget about the power of selectivity.
RECORD
|
Already taken place We, 30.6.2021
We, 30.6.2021
SelectScience
tag
share
more
The power of (U)HPLC selectivity for diverse pharmaceutical methods
Advances in Proteomics & Metabolomics 2021

Advances in Proteomics & Metabolomics 2021

This event features a collection of exclusive talks from leading scientists in the field, discussing their research and lending insights on the advances and challenges in this exciting space.
RECORD
|
Already taken place We, 30.6.2021
We, 30.6.2021
Technology Networks
tag
share
more
Advances in Proteomics & Metabolomics 2021
High-throughput screening symposium - Day 2

High-throughput screening symposium - Day 2

This is your chance to hear first-hand from industry leaders who are revolutionizing high-throughput quantitative analysis using Acoustic Ejection Mass Spectrometry (AEMS).
RECORD
|
Already taken place We, 30.6.2021
We, 30.6.2021
SCIEX
tag
share
more
High-throughput screening symposium - Day 2
Automated workflow for mRNA sequencing by High Resolution LCMS

Automated workflow for mRNA sequencing by High Resolution LCMS

In this webinar we will discuss the use of an automated workflow which includes enzymatic digestion, high resolution LCMS analysis, and data analysis for mRNA sequencing.
RECORD
|
Already taken place Tu, 29.6.2021
Tu, 29.6.2021
Thermo Fisher Scientific
tag
share
more
Automated workflow for mRNA sequencing by High Resolution LCMS
Determination of Dimethylamine and Nitrite in Pharmaceuticals by Ion Chromatography to Assess the Likelihood of Nitrosamine Formation

Determination of Dimethylamine and Nitrite in Pharmaceuticals by Ion Chromatography to Assess the Likelihood of Nitrosamine Formation

The developed methods should be useful for the rapid screening and quantification of nitrite and DMA in pharmaceuticals and in-process sample to assess the likelihood of NDMA formation.
RECORD
|
Already taken place Tu, 29.6.2021
Tu, 29.6.2021
Thermo Fisher Scientific
tag
share
more
Determination of Dimethylamine and Nitrite in Pharmaceuticals by Ion Chromatography to Assess the Likelihood of Nitrosamine Formation
 

Related content

PFAS, Mycotoxins & Food Safety Testing with SCIEX's Holly Lee

PFAS, Mycotoxins & Food Safety Testing with SCIEX's Holly Lee

Fr, 24.7.2026
Organomation
Prague Metabolism and Signaling Symposium brought together leading researchers in metabolism

Prague Metabolism and Signaling Symposium brought together leading researchers in metabolism

Fr, 24.7.2026
Institute of Organic Chemistry and Biochemistry of the Czech Academy of Sciences
2D-LC (Two-dimensional Liquid Chromatography): What, When and Why to Use it

2D-LC (Two-dimensional Liquid Chromatography): What, When and Why to Use it

Th, 23.7.2026
Phenomenex
Other projects
GCMS
ICPMS
Follow us
FacebookX (Twitter)LinkedInYouTube
More information
WebinarsAbout usContact usTerms of use
LabRulez s.r.o. All rights reserved. Content available under a CC BY-SA 4.0 Attribution-ShareAlike